Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin for cognitive impairment in children with neurofibromatosis type 1
ACTRN12607000560493Phase 2Completed
- Sponsor
- Prof Kathryn North
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised trial in neurofibromatosis type 1 (NF1) comparing Lovastatin with Placebo (2 arms). Primary endpoints: Visuospatial learning and Sustained attention. Started Jul 2009; status: completed.
02
Drugs
lovastatin
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on ACTRN12607000560493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000560493.